Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets
AbstractIn the past decade, it was observed that the relationship between the emerging New Molecular Entities and the quantum of R&D investment has not been favorable. There might be numerous reasons but few studies stress the introduction of target based drug discovery approach as one of the factors. Although a number of drugs have been developed with an emphasis on a single protein target, yet identification of valid target is complex. The approach focuses on an in vitro single target, which overlooks the complexity of cell and makes process of validation drug targets uncertain. Thus, it is imperative to search for alternatives rather than looking at success stories of target-based drug discovery. It would be beneficial if the drugs were developed to target multiple components. New approaches like reverse engineering and translational research need to take into account both system and target-based approach. This review evaluates the strengths and limitations of known drug discovery approaches and proposes alternative approaches for increasing efficiency against treatment. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 934 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Vasaikar, S.; Bhatia, P.; Bhatia, P.G.; Chu Yaiw, K. Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets. Biomedicines 2016, 4, 27.
Vasaikar S, Bhatia P, Bhatia PG, Chu Yaiw K. Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets. Biomedicines. 2016; 4(4):27.Chicago/Turabian Style
Vasaikar, Suhas; Bhatia, Pooja; Bhatia, Partap G.; Chu Yaiw, Koon. 2016. "Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets." Biomedicines 4, no. 4: 27.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.